Research Paper Volume 13, Issue 12 pp 16445—16470
Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia
Figure 9. The differential expression of critical genes in clinical samples between AML and healthy individuals. The result of clinical validation showed that ITGB2-AS, ITGAM, and PPBP are significantly higher in the initial diagnosed AML. ***P < 0.001; *P < 0.05.